0001209191-19-005224.txt : 20190124
0001209191-19-005224.hdr.sgml : 20190124
20190124182843
ACCESSION NUMBER: 0001209191-19-005224
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190122
FILED AS OF DATE: 20190124
DATE AS OF CHANGE: 20190124
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mattsson Jan
CENTRAL INDEX KEY: 0001687436
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33451
FILM NUMBER: 19540872
MAIL ADDRESS:
STREET 1: C/O ALBIREO PHARMA, INC.
STREET 2: 50 MILK STREET, 16TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02109
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALBIREO PHARMA, INC.
CENTRAL INDEX KEY: 0001322505
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10 POST OFFICE SQUARE
STREET 2: SUITE 502 SOUTH
CITY: BOSTON
STATE: MA
ZIP: 02109
BUSINESS PHONE: 857-415-4774
MAIL ADDRESS:
STREET 1: 10 POST OFFICE SQUARE
STREET 2: SUITE 502 SOUTH
CITY: BOSTON
STATE: MA
ZIP: 02109
FORMER COMPANY:
FORMER CONFORMED NAME: Biodel Inc
DATE OF NAME CHANGE: 20050331
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-01-22
0
0001322505
ALBIREO PHARMA, INC.
ALBO
0001687436
Mattsson Jan
C/O ALBIREO PHARMA INC.
10 POST OFFICE SQUARE, SUITE 502 SOUTH
BOSTON
MA
02109
0
1
0
0
Chief Operating Officer
Stock Option (right to buy)
24.04
2019-01-22
4
A
0
31500
0.00
A
2029-01-21
Common Stock
31500
31500
D
This option vests as to 25% of the shares on January 22, 2020 with the remainder vesting in equal installments every three months thereafter, beginning on April 22, 2020 and ending on January 22, 2023.
/s/ Jason Duncan, Attorney-in-fact
2019-01-24